Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

70.56
+1.021.47%
Post-market: 70.560.00000.00%19:30 EDT
Volume:691.02K
Turnover:48.59M
Market Cap:5.89B
PE:-115.67
High:70.84
Open:69.42
Low:69.05
Close:69.54
52wk High:90.87
52wk Low:49.38
Shares:83.46M
Float Shares:77.19M
Volume Ratio:1.00
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.61
PE(LYR):9.07

Loading ...

PTC Therapeutics (PTCT) Stock May Trade Above Fair Value Despite An 81% Run

Simply Wall St.
·
2 hours ago

PTC Therapeutics to Buy Drug Candidate from Sangamo for up to $211M

Dow Jones
·
Aug 29

PTC Therapeutics Director Michael Schmertzler Disposes of USD 1.82 Million in Common Shares

Reuters
·
Aug 29

PTC Therapeutics Acquires ST-920 Fabry Gene Therapy Rights

TIPRANKS
·
Aug 29

Broader Sephience PKU Data Could Be A Game Changer For PTC Therapeutics (PTCT)

Simply Wall St.
·
Aug 28

PTC Therapeutics Executives to Speak at Wells Fargo Healthcare Conference

Reuters
·
Aug 27

PTC Therapeutics Reports New Sephience PKU Trial and Real-World Data Showing Sustained Phe Control, Diet Liberalization

Reuters
·
Aug 24

PTC Therapeutics Director Michael Schmertzler Sells 24,000 Shares for $1.73 Million

Reuters
·
Aug 22

PTC Therapeutics Steps Into Rheumatoid Arthritis With New Phase 2 Study of PTC844

TIPRANKS
·
Aug 22

PTC Therapeutics Exec. VP and CLO Mark Elliott Boulding Disposes of 2,813 Common Shares Worth $204,863.91

Reuters
·
Aug 20

The Bull Case For PTC Therapeutics (PTCT) Could Change Following Renal Data Progress For ST-920

Simply Wall St.
·
Aug 20

PTC Therapeutics Sets Up Long-Term FA Study, Adding a New Catalyst for PTCT Investors

TIPRANKS
·
Aug 15

PTC Therapeutics : Barclays Raises Target Price to $122 from $120

THOMSON REUTERS
·
Aug 14

Barclays Sticks to Their Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 14

Cantor Fitzgerald Sticks to Their Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 13

Bank of America Securities Reaffirms Their Buy Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 13

PTC Therapeutics to Acquire ST-920 Fabry Gene Therapy

TIPRANKS
·
Aug 13

PTC Therapeutics, Inc. : Wells Fargo Raises Target Price to $109 from $106

THOMSON REUTERS
·
Aug 13

Sangamo Selects Winning Bids in Chapter 11 Asset Auction for USD 163.55 Million Cash at Close

Reuters
·
Aug 13

PTC Therapeutics to Buy Sangamo’s ST-920 Fabry Gene Therapy Program for $111 Million Upfront

Reuters
·
Aug 13